Plasma Markers of Neutrophil Extracellular ...
Document type :
Compte-rendu et recension critique d'ouvrage
Permalink :
Title :
Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients
Author(s) :
Prevel, Renaud [Auteur]
Microbiologie Fondamentale et Pathogénicité [MFP]
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Dupont, Annabelle [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Labrouche-Colomer, S. [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Garcia, Geoffrey [Auteur]
HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 [HEMATIM]
Dewitte, Antoine [Auteur]
Service Anesthésie - Réanimation [Bordeaux]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Bioingénierie tissulaire [BIOTIS]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Rauch, Antoine [Auteur]
Interface sang vaisseaux et réparation cardiovasculaire
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
GOUTAY, Julien [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Caplan, Morgan [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Jozefowicz, E. [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Lanoix, Jean-Philippe [Auteur]
CHU Amiens-Picardie
Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 [AGIR ]
Poissy, Julien [Auteur]
1001889|||Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 [UGSF] (VALID)
Riviere, Etienne [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Orieux, Arthur [Auteur]
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Université de Bordeaux [UB]
Malvy, Denis [Auteur]
Bordeaux population health [BPH]
Global Health in the Global South [GHiGS]
Epidémiologie et Biostatistique [Bordeaux]
Université Victor Segalen - Bordeaux 2
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Service de médecine interne et maladies tropicales
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Gruson, Didier [Auteur]
Microbiologie Fondamentale et Pathogénicité [MFP]
Centre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
Hôpital Pellegrin
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
CHU Saint-Antoine [AP-HP]
Garcon, Loic [Auteur]
Université de Picardie Jules Verne [UPJV]
Laboratoire d'Hématologie [CHU Amiens]
HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 [HEMATIM]
CHU Amiens-Picardie
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
CHU Saint-Antoine [AP-HP]
Susen, Sophie [Auteur]
Interface sang vaisseaux et réparation cardiovasculaire
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
James, Chloé [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
CHU Pessac
University of Salford
Université de Bordeaux [UB]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Microbiologie Fondamentale et Pathogénicité [MFP]
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Dupont, Annabelle [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
Labrouche-Colomer, S. [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Garcia, Geoffrey [Auteur]
HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 [HEMATIM]
Dewitte, Antoine [Auteur]
Service Anesthésie - Réanimation [Bordeaux]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Bioingénierie tissulaire [BIOTIS]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Rauch, Antoine [Auteur]
Interface sang vaisseaux et réparation cardiovasculaire
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
GOUTAY, Julien [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Caplan, Morgan [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Jozefowicz, E. [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Lanoix, Jean-Philippe [Auteur]
CHU Amiens-Picardie
Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 [AGIR ]
Poissy, Julien [Auteur]
1001889|||Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 [UGSF] (VALID)
Riviere, Etienne [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
Orieux, Arthur [Auteur]
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Université de Bordeaux [UB]
Malvy, Denis [Auteur]
Bordeaux population health [BPH]
Global Health in the Global South [GHiGS]
Epidémiologie et Biostatistique [Bordeaux]
Université Victor Segalen - Bordeaux 2
CHU de Bordeaux Pellegrin [Bordeaux]
Hôpital Pellegrin
Service de médecine interne et maladies tropicales
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Gruson, Didier [Auteur]
Microbiologie Fondamentale et Pathogénicité [MFP]
Centre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] [CRCTB]
Hôpital Pellegrin
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
CHU Saint-Antoine [AP-HP]
Garcon, Loic [Auteur]
Université de Picardie Jules Verne [UPJV]
Laboratoire d'Hématologie [CHU Amiens]
HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666 [HEMATIM]
CHU Amiens-Picardie
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
CHU Saint-Antoine [AP-HP]
Susen, Sophie [Auteur]
Interface sang vaisseaux et réparation cardiovasculaire
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital cardiologique
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U 1011 [RNMCD]
James, Chloé [Auteur]
Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
CHU Pessac
University of Salford
Université de Bordeaux [UB]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Journal title :
Frontiers in immunology
Volume number :
13
Pages :
851497
Publisher :
Frontiers
Publication date :
2022
ISSN :
1664-3224
English keyword(s) :
neutrophil extracellular trap
acute respiratory distress syndrome
COVID-19
immunothrombosis
pulmonary embolism
acute respiratory distress syndrome
COVID-19
immunothrombosis
pulmonary embolism
HAL domain(s) :
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Maladies infectieuses
Sciences du Vivant [q-bio]/Immunologie/Immunité innée
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Maladies émergentes
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Pneumologie et système respiratoire
Sciences du Vivant [q-bio]/Immunologie/Immunité innée
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Maladies émergentes
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Pneumologie et système respiratoire
English abstract : [en]
ntroduction: Coronavirus disease 2019 (COVID-19) can cause life-threatening acute respiratory distress syndrome (ARDS). Recent data suggest a role for neutrophil extracellular traps (NETs) in COVID-19-related lung damage ...
Show more >ntroduction: Coronavirus disease 2019 (COVID-19) can cause life-threatening acute respiratory distress syndrome (ARDS). Recent data suggest a role for neutrophil extracellular traps (NETs) in COVID-19-related lung damage partly due to microthrombus formation. Besides, pulmonary embolism (PE) is frequent in severe COVID-19 patients, suggesting that immunothrombosis could also be responsible for increased PE occurrence in these patients. Here, we evaluate whether plasma levels of NET markers measured shorty after admission of hospitalized COVID-19 patients are associated with clinical outcomes in terms of clinical worsening, survival, and PE occurrence.Patients and Methods: Ninety-six hospitalized COVID-19 patients were included, 50 with ARDS (severe disease) and 46 with moderate disease. We collected plasma early after admission and measured 3 NET markers: total DNA, myeloperoxidase (MPO)–DNA complexes, and citrullinated histone H3. Comparisons between survivors and non-survivors and patients developing PE and those not developing PE were assessed by Mann–Whitney test.Results: Analysis in the whole population of hospitalized COVID-19 patients revealed increased circulating biomarkers of NETs in patients who will die from COVID-19 and in patients who will subsequently develop PE. Restriction of our analysis in the most severe patients, i.e., the ones who enter the hospital for COVID-19-related ARDS, confirmed the link between NET biomarker levels and survival but not PE occurrence.Conclusion: Our results strongly reinforce the hypothesis that NETosis is an attractive therapeutic target to prevent COVID-19 progression but that it does not seem to be linked to PE occurrence in patients hospitalized with COVID-19.Show less >
Show more >ntroduction: Coronavirus disease 2019 (COVID-19) can cause life-threatening acute respiratory distress syndrome (ARDS). Recent data suggest a role for neutrophil extracellular traps (NETs) in COVID-19-related lung damage partly due to microthrombus formation. Besides, pulmonary embolism (PE) is frequent in severe COVID-19 patients, suggesting that immunothrombosis could also be responsible for increased PE occurrence in these patients. Here, we evaluate whether plasma levels of NET markers measured shorty after admission of hospitalized COVID-19 patients are associated with clinical outcomes in terms of clinical worsening, survival, and PE occurrence.Patients and Methods: Ninety-six hospitalized COVID-19 patients were included, 50 with ARDS (severe disease) and 46 with moderate disease. We collected plasma early after admission and measured 3 NET markers: total DNA, myeloperoxidase (MPO)–DNA complexes, and citrullinated histone H3. Comparisons between survivors and non-survivors and patients developing PE and those not developing PE were assessed by Mann–Whitney test.Results: Analysis in the whole population of hospitalized COVID-19 patients revealed increased circulating biomarkers of NETs in patients who will die from COVID-19 and in patients who will subsequently develop PE. Restriction of our analysis in the most severe patients, i.e., the ones who enter the hospital for COVID-19-related ARDS, confirmed the link between NET biomarker levels and survival but not PE occurrence.Conclusion: Our results strongly reinforce the hypothesis that NETosis is an attractive therapeutic target to prevent COVID-19 progression but that it does not seem to be linked to PE occurrence in patients hospitalized with COVID-19.Show less >
Language :
Anglais
Popular science :
Non
Collections :
Research team(s) :
Glycobiology in fungal Pathogenesis and Clinical Applications
Submission date :
2024-02-27T16:46:10Z
Files
- https://hal.archives-ouvertes.fr/hal-03626002/document
- Open access
- Access the document
- https://www.frontiersin.org/articles/10.3389/fimmu.2022.851497/pdf
- Open access
- Access the document
- https://hal.archives-ouvertes.fr/hal-03626002/document
- Open access
- Access the document
- document
- Open access
- Access the document
- BMC_Front.%20Immunol_2022_PREVEL.pdf
- Open access
- Access the document
- Open access
- Access the document